DK1246828T3 - Benzosulfoner med calciummantagonist-aktivitet - Google Patents

Benzosulfoner med calciummantagonist-aktivitet

Info

Publication number
DK1246828T3
DK1246828T3 DK00988414T DK00988414T DK1246828T3 DK 1246828 T3 DK1246828 T3 DK 1246828T3 DK 00988414 T DK00988414 T DK 00988414T DK 00988414 T DK00988414 T DK 00988414T DK 1246828 T3 DK1246828 T3 DK 1246828T3
Authority
DK
Denmark
Prior art keywords
benzosulfones
antagonist activity
calcium antagonist
calcium
activity
Prior art date
Application number
DK00988414T
Other languages
Danish (da)
English (en)
Inventor
John H Dodd
James L Bullington
Kenneth C Rupert
Daniel A Hall
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1246828T3 publication Critical patent/DK1246828T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK00988414T 2000-01-12 2000-12-28 Benzosulfoner med calciummantagonist-aktivitet DK1246828T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17565000P 2000-01-12 2000-01-12

Publications (1)

Publication Number Publication Date
DK1246828T3 true DK1246828T3 (da) 2006-04-03

Family

ID=22641084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00988414T DK1246828T3 (da) 2000-01-12 2000-12-28 Benzosulfoner med calciummantagonist-aktivitet

Country Status (14)

Country Link
US (1) US6410553B1 (de)
EP (1) EP1246828B1 (de)
JP (1) JP2003519626A (de)
CN (1) CN1301997C (de)
AR (1) AR026834A1 (de)
AT (1) ATE312106T1 (de)
AU (1) AU783470B2 (de)
CA (1) CA2396962A1 (de)
DE (1) DE60024675T2 (de)
DK (1) DK1246828T3 (de)
ES (1) ES2254258T3 (de)
MX (1) MXPA02006842A (de)
MY (1) MY128383A (de)
WO (1) WO2001051493A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4705785A (en) 1986-04-09 1987-11-10 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
KR20020027350A (ko) 1999-06-14 2002-04-13 오르토-맥네일 파마슈티칼, 인코퍼레이티드 디티에피노[6,5-ｂ]피리딘 및 관련된 조성물 및 방법

Also Published As

Publication number Publication date
US20020049326A1 (en) 2002-04-25
MY128383A (en) 2007-01-31
MXPA02006842A (es) 2004-04-05
AU2462401A (en) 2001-07-24
DE60024675D1 (de) 2006-01-12
ES2254258T3 (es) 2006-06-16
EP1246828B1 (de) 2005-12-07
EP1246828A1 (de) 2002-10-09
AR026834A1 (es) 2003-02-26
DE60024675T2 (de) 2006-08-24
JP2003519626A (ja) 2003-06-24
CN1451010A (zh) 2003-10-22
ATE312106T1 (de) 2005-12-15
CA2396962A1 (en) 2001-07-19
US6410553B1 (en) 2002-06-25
WO2001051493A1 (en) 2001-07-19
CN1301997C (zh) 2007-02-28
AU783470B2 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DE60026169D1 (de) Selektive neurokinin-antagonisten
ATE307121T1 (de) Substituierte arylpyrazine
ID29996A (id) Penentuan lokasi menggunakan regresi daerah bobot
AR028393A1 (es) Iminoazidas substituidas
DE60124963D1 (de) Befestigungsmittel
NO20031332L (no) Arylalkan-sulfonamider med endothelin-antagonistaktivitet
ATE365721T1 (de) Substituierte benzoylcyclohexenone
AR028302A1 (es) Feniluracilos substituidos
DE50103720D1 (de) Befestigungselement
DE60103797D1 (de) Befestigungselement
NO20010680D0 (no) Anleggsovervåkingssystem
ITFI20000148A0 (it) Traversina per strutture canaliformi
UA4004S (uk) Шпала
NO20021908L (no) Absorberende gjenstand med forbedret innfestingssystem
ITMI20000805A0 (it) Lettino termale-estetico
FI20000909A0 (fi) Vuode
SE0102721L (sv) Förankringsdon
FI4842U1 (fi) Paino
ITMI20002088A0 (it) Nessuna
FI4659U1 (fi) Kiinnityselin
FI20000423A0 (fi) Kiinnityselin
FI20001354A0 (fi) Kiinnitin
SE0004485D0 (sv) Fästelement
FI20000370A0 (fi) Kiinnitin
SE0002133D0 (sv) Fästanordning